Ridloff Elena 4
4 · Kymera Therapeutics, Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Ridloff Elena
Director
Transactions
- Sale
Common Stock
2025-06-11$50.00/sh−4,500$225,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-11−4,500→ 4,500 totalExercise: $20.29Exp: 2032-06-29→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2025-06-11$20.29/sh+4,500$91,305→ 4,500 total
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated November 25, 2024 adopted by the reporting person.
- [F2]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following the vesting commencement date of June 29, 2022, subject to the reporting person's continued service relationship through each vesting date.